CCM
GSK icon

Cinctive Capital Management’s GSK GSK Stock Holding History

Cinctive Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-67,804
Closed -$3.33M – 432
2025
Q4 		$3.33M Buy
+67,804
New +$3.16M 0.18% 155
2024
Q3 		– Sell
-94,608
Closed -$3.64M – 437
2024
Q2 		$3.64M Buy
94,608
+50,333
+114% +$2.12M 0.17% 182
2024
Q1 		$1.9M Buy
+44,275
New +$1.83M 0.09% 226
2022
Q3 		– Sell
-80,622
Closed -$4.39M – 525
2022
Q2 		$4.39M Buy
80,622
+20,706
+35% +$1.14M 0.18% 180
2022
Q1 		$3.26M Sell
59,916
-26,441
-31% -$1.44M 0.12% 259
2021
Q4 		$4.76M Buy
+86,357
New +$4.49M 0.21% 164

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cinctive Capital Management's GSK Position: Q1 2026 in Review

Cinctive Capital Management sold out of GSK (GSK) in Q1 2026, closing a stake of 67,804 shares — an estimated $3.33M sold.

Cinctive Capital Management first reported a position in GSK in Q4 2021 and held it in 6 quarters. The position peaked at $4.76M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Cinctive Capital Management reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 67,804 GSK shares in Q1 2026, an estimated $3.33M.
  • Cinctive Capital Management first reported a position in GSK in Q4 2021 and held it in 6 quarters.
  • Cinctive Capital Management's GSK position peaked at $4.76M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.